CAPE TOWN, South Africa, Aug. 16 /PRNewswire/ -- Infectious diseases are rampant in sub-Saharan Africa. Urbanisation and westernised lifestyles have further increased the prevalence of non-communicable diseases such as cancer. The strong correlation between infectious diseases and cancer has additionally fuelled the incidence rates of various cancers, driving the pharmaceutical industry in key east African countries.
"Although the management and prevention of infectious diseases has been the priority in sub-Saharan Africa, there is scant attention towards rising lifestyle diseases," says Frost & Sullivan programme manager Lizelle Wentzel. "For example, Uganda has one cancer institute, three oncologists and limited funding, but is attempting to make a difference through research collaborations, funding programmes, and training of staff to control the spread of cancer in the country."
New analysis from Frost & Sullivan (http://www.pharma.frost.com), The Pharmaceutical Industry in Key East African Countries, finds that the market earned revenues of $1.2 million in 2009 and estimates this to reach $2.8 million in 2016. The products covered in this study span the cardiovascular, respiratory, central nervous system, anti-infectives, oncology and diabetes sectors.
If you are interested in more information on this study, please send an e-mail to Patrick Cairns, Corporate Communications, at firstname.lastname@example.org, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.
"Realising the growing burd